| 000 | 01627 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516081215.0 | ||
| 264 | 0 | _c20120810 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1873-2763 | ||
| 024 | 7 |
_a10.1016/j.bone.2012.02.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnastasilakis, Athanasios D | |
| 245 | 0 | 0 |
_aAcute phase response following intravenous zoledronate in postmenopausal women with low bone mass. _h[electronic resource] |
| 260 |
_bBone _cMay 2012 |
||
| 300 |
_a1130-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAcute-Phase Reaction _xchemically induced |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrgan Size _xdrug effects |
| 650 | 0 | 4 |
_aPostmenopause _xdrug effects |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aPolyzos, Stergios A | |
| 700 | 1 | _aMakras, Polyzois | |
| 700 | 1 | _aSakellariou, Grigorios T | |
| 700 | 1 | _aBisbinas, Ilias | |
| 700 | 1 | _aGkiomisi, Athina | |
| 700 | 1 | _aDelaroudis, Sideris | |
| 700 | 1 | _aGerou, Spyridon | |
| 700 | 1 | _aBallaouri, Iris | |
| 700 | 1 | _aOikonomou, Dimitrios | |
| 700 | 1 | _aPapapoulos, Socrates E | |
| 773 | 0 |
_tBone _gvol. 50 _gno. 5 _gp. 1130-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bone.2012.02.006 _zAvailable from publisher's website |
| 999 |
_c21575626 _d21575626 |
||